Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 107391

In scope icon M 7 C
QID 107391 (Type "107391" in App Search)
A 25-year-old male presents to your clinic complaining of a yellow discharge from his urethra. He states that for the past week he has had pain with urination and yesterday the discharge developed. He admits to unprotected sex with multiple sexual partners. Gram stain of the discharge is shown in Figure A. What is the most appropriate treatment for this patient's condition?
  • A

Doxycycline

0%

0/8

Penicillin G

0%

0/8

Ceftriaxone

12%

1/8

Azithromycin

0%

0/8

Ceftriaxone and azithromycin

88%

7/8

  • A

Select Answer to see Preferred Response

bookmode logo Review TC In New Tab

This patient has an uncomplicated gonorrheal urethritis that should be treated with an injection of ceftriaxone. Patients treated for gonorrhea should also be treated with azithromycin or doxycycline for chlamydial co-infection.

Gonorrhea is the second most common sexually transmitted infection (behind chlamydia), and is a common cause of urethritis in men or cervicitis in women. The causative organism is Neisseria gonorrhoeae, a gram-negative intracellular diplococcus. Patients typically present with purulent yellow-green discharge, dysuria, urinary frequency, and a solitary erythematous nodule on the penile shaft.

Mayor et al. review the diagnosis and treatment of gonococcal infections. They warn that gonorrhea in women is often asymptomatic and that, if left untreated, can progress to pelvic inflammatory disease or disseminated disease. They state that while Neisseria gonorrhoeae most commonly affects the urogenital area, it can also cause anorectal, pharyngeal, and conjunctival infections. Gram stain, urine nucleic amplification tests, or urine polymerase chain reaction testing (in men) can all be used for diagnosis and have similar sensitivity and specificity.

Meyers et al. review the U.S. Preventive Services Task Force's (USPSTF) screening recommendations for sexually transmitted infections. The USPSTF recommends screening all sexually active women younger than 25 years of age for chlamydia and gonorrhea. They further recommend screening for chlamydia, gonorrhea, HIV, and syphilis in women older than 25 years of age with risk factors for sexually transmitted infections, such as unprotected sexual intercourse, having a new sexual partner, having multiple sexual partners, exchanging sex for drugs or money, or engaging in sex while under the influence of drugs or alcohol. Women older than 25 years of age without risk factors should not be screened. The USPSTF recommends screening for HIV and syphilis only in men who are at high risk of infection.

Figure A demonstrates a gram stain from a patient with acute gonococcal urethritis. Neisseria gonorrhoeae, a gram-negative intracellular diplococci, is present.

Incorrect answers:
Answer 1: Doxycycline is used in the treatment of chlamydia, not gonorrhea.
Answer 2: Penicillin G is used in the treatment of syphilis, not gonorrhea.
Answer 3: Ceftriaxone is an appropriate treatment for gonorrheal urethritis, however, it should be combined with either azithromycin or doxycycline in order to treat chlamydial co-infection.
Answer 4: Azithromycin is used in the treatment of chlamydia, not gonorrhea.

REFERENCES (2)
Authors
Rating
Please Rate Question Quality

0.0

  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon

(0)

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options